TY - PAT
T1 - Cholesteryl ester transfer protein (cetp) inhibition in the treatment of cancer
AU - Kaur, Mandeep
AU - Esau, Luke E.
AU - Sagar, Sunii
N1 - KAUST Repository Item: Exported on 2019-02-13
PY - 2016/9/1
Y1 - 2016/9/1
N2 - In one embodiment, the invention provides methods of treatment which use therapeutically effective amounts of Choleste ryl Ester Transfer Protein (CETP) inhibitors to treat a variety of cancers. In certain embodiments, the inhibitor is a CETP-inhibiting small molecule, CETP-inhibiting antisense oligonucleotide, CETP-inhibiting siRNA or a CETP- inhibiting antibody. Related pharmaceutical compositions, kits, diagnostics and screens are also provided.
AB - In one embodiment, the invention provides methods of treatment which use therapeutically effective amounts of Choleste ryl Ester Transfer Protein (CETP) inhibitors to treat a variety of cancers. In certain embodiments, the inhibitor is a CETP-inhibiting small molecule, CETP-inhibiting antisense oligonucleotide, CETP-inhibiting siRNA or a CETP- inhibiting antibody. Related pharmaceutical compositions, kits, diagnostics and screens are also provided.
UR - http://hdl.handle.net/10754/621914
UR - http://www.google.com/patents/WO2016135633A1
UR - http://worldwide.espacenet.com/publicationDetails/biblio?CC=WO&NR=2016135633A1&KC=A1&FT=D
M3 - Patent
M1 - WO 2016135633 A1
ER -
